Lenexa, KS (PRWEB) February 10, 2016
On February 19 at BMT Tandem Meetings 2016, Dr. Michael Chez will present “Using Stem Cell Therapy to Treat Autism.”
During this live presentation, Dr. Chez, who is the director of Pediatric Research at Sutter Neurological Research Consortium and director of the Pediatric Epilepsy and Autism programs in the Sutter Sacramento Region, will discuss clinical applications and potential mechanisms of using stem cell therapy for treatments in autism.
One child in 68 is diagnosed with disorders on the autism spectrum in the U.S., and studies outside the U.S. have shown improved clinical outcomes from stem cell treatments. Dr. Chez will review the medical and scientific findings in autism that may make stem cell therapy a potential intervention strategy for the treatment of this disorder. He will also review historical case reports, and Dr. Chez, who was the primary investigator in the first study in the U.S. using autologous cord blood stem cell infusion in autism, will discuss the safety and clinical implementation in this double-blind, placebo-controlled trial. He will also address the future potential of using stem-cell-derived therapy for the treatment of autism.
Dr. Chez’s program is part of the popular “Share the Science” series sponsored by Mediware Information Systems, Inc. and Save the Cord Foundation. Share the Science is typically broadcast as a series of webinars and is an innovative educational program that brings the latest research and breakthroughs to the industry through unbiased and noncommercial presentations.
The event will be held at the Hawaii Convention Center from 7:00 a.m. to 8:30 a.m. Attendance is free, but space is limited, and registration is required. To register, go to http://www.mediware.com/DrChez, or stop by booth #315 for more information.
About Mediware Information Systems
Since 1980, Mediware has provided software solutions to healthcare providers and has since expanded to serve many state and federal agencies. Mediware’s solutions are perfect for high-growth, complex patient care environments that remain underserved by existing vendors. The company employs more than 500 subject matter experts who deeply understand business and care processes in highly specialized acute, non-acute and community-based care settings and have years of experience integrating systems. Mediware’s portfolio of solutions currently includes long term services and supports, blood solutions, cellular therapy, home care, medication management, rehabilitation, and respiratory therapy. For more information about Mediware products and services, visit http://www.mediware.com.
About Save the Cord Foundation
Save the Cord Foundation is a 501(c)(3) non-profit organization that was established to create and provide education and awareness and to distribute unbiased, factual information concerning the lifesaving benefits of cord blood and the need to preserve this valuable medical resource. The organization prides itself on providing resources and guidance to parents on private and public cord blood preservation. To learn more, visit http://www.savethecordfoundation.org/.